Janssen Pharmaceuticals Inc.

10/21/2019 | Press release | Distributed by Public on 10/21/2019 17:30

STELARA® (ustekinumab) Data Demonstrate Long-Term Efficacy and Safety Results in Adults with Moderately to Severely Active Ulcerative Colitis in Phase 3 Extension Trial